Set [menp]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
Detection [topp]    
Tract [bpoc]    
CANCER [neop]    
Cytology brush [medd]    
Sample [sbst]    
Aims [idcn]    
CANCER [neop]    
Detected [fndg]    
Fluorescence in situ hybridisation [mbrt]    
Brush, NOS [mnob]    
Sample [sbst]    
Probes [medd]    
Design [acty]    
detect [fndg]    
BLADDER CANCER [neop]    
Design [acty]    
Set [menp]    
NEW [qlco]    
Probes [medd]    
detect [fndg]    
CANCER [neop]    
Compared [acty]    
Performance [inbe]    
Routine [qlco]    
Cytology [lbpr]    
Methods [inpr]    
tested [inpr]    
Set [menp]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
Tumour tissue [tisu]    
Cholangiocarcinoma [neop]    
PANCREATIC CARCINOMA [neop]    
Tumour tissue [tisu]    
Patients [podg]    
Identified [qlco]    
Probes [medd]    
Specificity [qnco]    
Tumour NOS [neop]    
Tumour tissue [tisu]    
Call [menp]    
Set [menp]    
Probes [medd]    
Fluorescence in situ hybridisation [mbrt]    
Performed [ftcn]    
retrospective [resa]    
Brush, NOS [mnob]    
Sample [sbst]    
Patients [podg]    
Endoscopic retrograde cholangio-pancreatography [diap]    
Evaluation [hlca]    
MALIGNANCY [neop]    
Mayo [geoa]    
Available [ftcn]    
Routine [qlco]    
Cytology [lbpr]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
Archive [mnob]    
Residual [qlco]    
specimens [sbst]    
Evaluate [hlca]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
Cutoff [ftcn]    
Values [qlco]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
Sample [sbst]    
Remaining [qlco]    
Sample [sbst]    
MALIGNANCY [neop]    
Tract [bpoc]    
> 2 years [fndg]    
Brush, NOS [mnob]    
sample collection [lbpr]    
Standard [qlco]    
Sample [sbst]    
Patients [podg]    
MALIGNANCIES [neop]    
Validation [resa]    
included [ftcn]    
Patients [podg]    
MALIGNANCIES [neop]    
Patients [podg]    
CHOLANGITIS, PRIMARY SCLEROSING [dsyn]    
Sample [sbst]    
Containing [ftcn]    
Cells [cell]    
Cutoff [ftcn]    
Polysomy [comd]    
Copy Number [qnco]    
Gain [qnco]    
Probes [medd]    
Classified [clas]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
Logistic Regression [resa]    
Estimate [qnco]    
Associations [menp]    
Pathologic findings [fndg]    
Fluorescence in situ hybridisation [mbrt]    
Combination [qlco]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
1q21 [celc]    
7p12 [celc]    
8q24 [celc]    
9p21 [celc]    
Identified [qlco]    
cancer cells [cell]    
Sensitivity [patf]    
Specificity [qnco]    
Tissue Sample [tisu]    
included [ftcn]    
PROBE [medd]    
Set [menp]    
Validation [resa]    
Brush, NOS [mnob]    
Sample [sbst]    
Fluorescence in situ hybridisation [mbrt]    
Identified [qlco]    
Sample [sbst]    
Patients [podg]    
MALIGNANCY [neop]    
Significantly high [qnco]    
Sensitivity [patf]    
Probes [medd]    
Routine [qlco]    
Cytology [lbpr]    
Specificity [qnco]    
>90 [qnco]    
Detection [topp]    
CARCINOMA [neop]    
Adjusted [ftcn]    
included [ftcn]    
Detection [topp]    
Polysomy [comd]    
Fluorescence in situ hybridisation [mbrt]    
MASS [fndg]    
Cross-sectional imaging [inpr]    
cancer cells [cell]    
Routine [qlco]    
Cytology [lbpr]    
absence [ftcn]    
CHOLANGITIS, PRIMARY SCLEROSING [dsyn]    
Conclusions [idcn]    
Identified [qlco]    
Set [menp]    
Fluorescence in situ hybridisation [mbrt]    
Probes [medd]    
detect [fndg]    
cancer cells [cell]    
Brush, NOS [mnob]    
Sample [sbst]    
Patients [podg]    
CHOLANGITIS, PRIMARY SCLEROSING [dsyn]    
Higher [qlco]    
Levels [qlco]    
Sensitivity [patf]    
Probes [medd]    
Cytologic [ftcn]    
Brushing [topp]    
test results [fndg]    
clinical Feature [clna]    
Detection [topp]    
CANCER [neop]    
Patients [podg]    
Cancers [neop]    
